Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

Clinical trial NCT01701037 · TERMINATED

Trial details

NCT number: NCT01701037
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IIB Melanoma (Locally Advanced)Stage IIC Melanoma (Locally Advanced)Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma (Limited, Resectable)

Start date: 2013-01-01
Primary completion: 2015-02-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.